SciClone Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 77   

Articles published

SCLN 8.76 +0.65 (8.01%)
price chart
SciClone Pharmaceuticals Inc. (SCLN) Jumps 8.14% on February 05
SciClone Pharmaceuticals Inc. (SCLN) was among the biggest gainers on the Russell 2000 for Friday February 05 as the stock popped 8.14% to $8.77, representing a gain of $0.66 per share.
Could SciClone Pharmaceuticals, Inc. Recover After Today's Gap Up?  Sonoran Weekly Review
SciClone Pharmaceuticals Inc.
SciClone Pharmaceuticals Inc. NASDAQ: SCLN. GO. Set Alerts · Find a Broker · Join TD Ameritrade · Market Index · Overview Profile News Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders.
Why SciClone Pharmaceuticals, Inc. Is Surging Higher
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Why SciClone Pharmaceuticals Is Soaring Today
So what: SciClone Pharmaceuticals' Zadaxin is an immune stimulating drug that is used to treat hepatitis B. The drug, which isn't available in the United States, is sold primarily in China, which is home to roughly one third of the globe's hepatitis B ...
SciClone Pharmaceuticals, Inc. (SCLN) Releases FY15 Earnings Guidance
SciClone Pharmaceuticals logo SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) issued an update on its FY15 earnings guidance on Monday morning.
SciClone Pharmaceuticals, Inc. (SCLN) Issues FY15 Earnings Guidance  Zolmax
Sciclone Pharma (SCLN) Prelim. FY15 Revenue Hits High-End of Outlook  StreetInsider.com
SciClone Pharmaceuticals Inc. (SCLN) Jumps 5.48% on January 20
SciClone Pharmaceuticals Inc. (SCLN) was among the biggest gainers on the Russell 2000 for Wednesday January 20 as the stock popped 5.48% to $8.08, representing a gain of $0.42 per share.
Best Stocks: Gartner Inc. (NYSE:IT), SciClone Pharmaceuticals, Inc. (NASDAQ ...
Gartner Inc. (NYSE:IT) on Thursday reported fourth-quarter profit of $65.8 million. On a per-share basis, the Stamford, Connecticut-based company said it had net income of 78 cents. Earnings, adjusted for costs related to mergers and acquisitions and ...
Sciclone Pharma (SCLN) Enters Settlement Over FCPA Violation Allegations; Will ...
SciClone Pharmaceuticals, Inc. (Nasdaq: SCLN) announced it has entered into a settlement agreement with the United States Securities and Exchange Commission (SEC) fully resolving the SEC's investigation into possible violations of the Foreign Corrupt ...
SciClone Pharmaceuticals Jumps 11% in After Hours; Pays $12.8 Mln to Settle ...  WallStreet.org
SciClone Announces Final Resolution With The Securities And Exchange ...  PR Newswire (press release)
Recent Broker Updates On SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)
Recently stock market analysts have updated their consensus ratings on shares of SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN).
SciClone Pharmaceuticals To Report Financial Results For The Third Quarter ...
FOSTER CITY, Calif., Oct. 26, 2015 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that it plans to report financial results for the third quarter 2015 on Monday, November 9, 2015.